This self-crossover, randomized controlled, pilot study aims to collect clinical data of bilateral stimulation of subthalamic nucleus (STN) combined with centromedian (CM) thalamus deep brain stimulation (DBS) for drug resistant epilepsy with motor symptom in adults.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
10
The DBS system is intended for patients with drug resistant motor epilepsy
Mean change in seizure frequency
Time frame: Baseline to after 3 month CM and CM+STN stimulation.
Adverse events related to DBS implantation
Time frame: After Device Inplanted to 12 month followup visit.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.